LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.21 | 770.25 | 751 | 904 | 0.8302 | -0.1034 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.21 | 770.25 | 1004 | 904 | 1.1099 | 2.1343 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.44 | 770.25 | 878 | 1012 | 0.8670 | 0.3932 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.44 | 770.25 | 1125 | 1012 | 1.1108 | 1.6100 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.66 | 770.25 | 954 | 1090 | 0.8752 | 0.5328 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.66 | 770.25 | 1216 | 1090 | 1.1156 | 1.4881 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.06 | 770.25 | 1043 | 1218 | 0.8560 | 0.5811 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.06 | 770.25 | 1364 | 1218 | 1.1194 | 1.3717 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.28 | 770.25 | 1152 | 1358 | 0.8482 | 0.6355 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.28 | 770.25 | 1515 | 1358 | 1.1155 | 1.2859 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.50 | 770.25 | 1211 | 1497 | 0.8088 | 0.6030 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.50 | 770.25 | 1633 | 1497 | 1.0907 | 1.1895 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.73 | 770.25 | 1254 | 1664 | 0.7534 | 0.5502 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.73 | 770.25 | 1684 | 1664 | 1.0117 | 1.0211 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.95 | 770.25 | 1303 | 1832 | 0.7111 | 0.5226 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.95 | 770.25 | 1732 | 1832 | 0.9452 | 0.9118 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.17 | 770.25 | 1367 | 2008 | 0.6807 | 0.5142 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.17 | 770.25 | 1819 | 2008 | 0.9057 | 0.8618 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.39 | 770.25 | 1403 | 2244 | 0.6251 | 0.4750 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.39 | 770.25 | 1887 | 2244 | 0.8407 | 0.7873 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.62 | 770.25 | 1484 | 2514 | 0.5901 | 0.4684 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 25.62 | 770.25 | 1995 | 2514 | 0.7933 | 0.7463 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.84 | 770.25 | 1574 | 2833 | 0.5554 | 0.4627 | MN20160304_L02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 27.84 | 770.25 | 2149 | 2833 | 0.7583 | 0.7262 | MN20160304_L02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 30.06 | 770.25 | 1689 | 3106 | 0.5438 | 0.4774 | MN20160304_L02 | D16 |